Research Priorities and Resource Allocation in the Investigation of New Drugs for Cancer in Least Developed Countries
المؤلفون المشاركون
Silva, Ricardo Eccard da
Andrade, Débora Dornelas Belchior Costa
Leite e Silva, Alessandra Vanessa
Carvalho, Marta Rodrigues de
Novaes, Maria Rita Carvalho Garbi
Amato, Angélica Amorim
المصدر
العدد
المجلد 2018، العدد 2018 (31 ديسمبر/كانون الأول 2018)، ص ص. 1-11، 11ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2018-07-02
دولة النشر
مصر
عدد الصفحات
11
التخصصات الرئيسية
الملخص EN
Cancer incidence has increased significantly in low- and middle-income countries.
The priorities of international health research are not always aligned with the global burden of cancer.
This study aims to analyze global tendencies in clinical trials in oncology and discuss research priorities and resource allocation in the investigation of new drugs for cancers that significantly affect the least developed countries.
This was a retrospective and analytical study that included data collected from the World Health Organization’s International Clinical Trials Registry Platform (ICTRP) in 2014.
According to our results, there was a tendency for clinical trials involving breast and lung cancer to be conducted in countries with a lower level of economic development.
On the other hand, cervical, stomach, and liver cancer, despite the significant burden that these place on middle- and low-income countries, were studied little among the countries selected.
In conclusion, the organizations that most fund research to develop new drugs for cancer treatment continue to show little interest in prioritizing resources to fund research for certain types of cancer such as those of the cervix, stomach, and liver, which have a significant impact in low- and middle-income countries.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Silva, Ricardo Eccard da& Amato, Angélica Amorim& Andrade, Débora Dornelas Belchior Costa& Leite e Silva, Alessandra Vanessa& Carvalho, Marta Rodrigues de& Novaes, Maria Rita Carvalho Garbi. 2018. Research Priorities and Resource Allocation in the Investigation of New Drugs for Cancer in Least Developed Countries. Journal of Oncology،Vol. 2018, no. 2018, pp.1-11.
https://search.emarefa.net/detail/BIM-1195867
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Silva, Ricardo Eccard da…[et al.]. Research Priorities and Resource Allocation in the Investigation of New Drugs for Cancer in Least Developed Countries. Journal of Oncology No. 2018 (2018), pp.1-11.
https://search.emarefa.net/detail/BIM-1195867
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Silva, Ricardo Eccard da& Amato, Angélica Amorim& Andrade, Débora Dornelas Belchior Costa& Leite e Silva, Alessandra Vanessa& Carvalho, Marta Rodrigues de& Novaes, Maria Rita Carvalho Garbi. Research Priorities and Resource Allocation in the Investigation of New Drugs for Cancer in Least Developed Countries. Journal of Oncology. 2018. Vol. 2018, no. 2018, pp.1-11.
https://search.emarefa.net/detail/BIM-1195867
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1195867
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر